AUAUniversity Podcast Series: Episode No. 108
An Overview of PARPi & Adverse Event Management
This podcast was funded by and developed in collaboration with AstraZeneca.
At the conclusion of this activity, participants will be able to:
- Identify approved PARP Inhibitors for prostate cancer and patients who may benefit from PARP Inhibitor‐based therapy.
- Evaluate available clinical safety and efficacy data for PARP Inhibitors.
- Describe indications and contraindications for PARP Inhibitors in patients with advanced prostate cancer.
- Identify how to manage adverse events that patients may experience while taking a PARP Inhibitors.
Host: Victor Nitti, MD
Co-Host: Stephen Freedland, MD